Works matching AU O'Dwyer, M.

Results: 72
    1
    2
    3
    4
    5

    3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant.

    Published in:
    Hematological Oncology, 2023, v. 41, p. 520, doi. 10.1002/hon.3164_385
    By:
    • Shah, B. D.;
    • Cassaday, R. D.;
    • Park, J. H.;
    • Houot, R.;
    • Oluwole, O. O.;
    • Logan, A. C.;
    • Boissel, N.;
    • Leguay, T.;
    • Bishop, M. R.;
    • Topp, M. S.;
    • O'Dwyer, K. M.;
    • Baer, M. R.;
    • Schiller, G. J.;
    • Abedi, M.;
    • Minnema, M. C.;
    • Stiff, P.;
    • Zhou, L.;
    • Hadjivassileva, T.;
    • Khalid, R. Damico;
    • Ghobadi, A. Armin
    Publication type:
    Article
    6
    7

    Configurational Activity.

    Published in:
    Nature, 1951, v. 167, n. 4260, p. 1036, doi. 10.1038/1671036a0
    By:
    • DWYER, F. P.;
    • GYARFAS, E. C.;
    • O'DWYER, M. F.
    Publication type:
    Article
    8
    9

    Role of myeloid cell leptin signaling in the regulation of glucose metabolism.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97549-0
    By:
    • Pereira, Sandra;
    • Cline, Daemon L.;
    • Chan, Melissa;
    • Chai, Kalin;
    • Yoon, Ji Soo;
    • O'Dwyer, Shannon M.;
    • Ellis, Cara E.;
    • Glavas, Maria M.;
    • Webber, Travis D.;
    • Baker, Robert K.;
    • Erener, Suheda;
    • Covey, Scott D.;
    • Kieffer, Timothy J.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 847, doi. 10.1016/j.clml.2022.07.011
    By:
    • Swan, D.;
    • Henderson, R.;
    • McEllistrim, C.;
    • Naicker, S.D.;
    • Quinn, J.;
    • Cahill, M.R.;
    • Mykytiv, V.;
    • Lenihan, E.;
    • Mulvaney, E.;
    • Nolan, M.;
    • Parker, I.;
    • Natoni, A.;
    • Lynch, K.;
    • Ryan, A.E.;
    • Szegezdi, E.;
    • Krawczyk, J.;
    • Murphy, P.;
    • O'Dwyer, M.
    Publication type:
    Article
    27

    KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL): Outcomes in Patients Who Were Treated with Prior Blinatumomab in ZUMA-3.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S184, doi. 10.1016/j.clml.2018.07.015
    By:
    • Shah, Bijal D.;
    • Oluwole, Olalekan O.;
    • Baer, Maria R.;
    • Bishop, Michael R.;
    • Holmes, Houston;
    • Schiller, Gary J.;
    • Donnellan, William;
    • O'Dwyer, Kristen M.;
    • Mardiros, Armen;
    • Rossi, John M.;
    • Shen, Tong;
    • Xue, Allen;
    • Jain, Rajul K.;
    • Vezan, Remus;
    • Wierda, William G.
    Publication type:
    Article
    28

    Flushing out the diagnosis.

    Published in:
    QJM: An International Journal of Medicine, 2013, v. 106, n. 12, p. 1121, doi. 10.1093/qjmed/hct148
    By:
    • Geoghegan, P.;
    • Moran, P.;
    • Sexton, D.J.;
    • O’Reilly, M.W.;
    • O’Dwyer, M.;
    • O’Regan, A.
    Publication type:
    Article
    29
    30
    31
    32
    33

    Discerning the painter's hand: machine learning on surface topography.

    Published in:
    Heritage Science, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40494-021-00618-w
    By:
    • Ji, F.;
    • McMaster, M. S.;
    • Schwab, S.;
    • Singh, G.;
    • Smith, L. N.;
    • Adhikari, S.;
    • O'Dwyer, M.;
    • Sayed, F.;
    • Ingrisano, A.;
    • Yoder, D.;
    • Bolman, E. S.;
    • Martin, I. T.;
    • Hinczewski, M.;
    • Singer, K. D.
    Publication type:
    Article
    34

    Discerning the painter's hand: machine learning on surface topography.

    Published in:
    Heritage Science, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40494-021-00618-w
    By:
    • Ji, F.;
    • McMaster, M. S.;
    • Schwab, S.;
    • Singh, G.;
    • Smith, L. N.;
    • Adhikari, S.;
    • O'Dwyer, M.;
    • Sayed, F.;
    • Ingrisano, A.;
    • Yoder, D.;
    • Bolman, E. S.;
    • Martin, I. T.;
    • Hinczewski, M.;
    • Singer, K. D.
    Publication type:
    Article
    35

    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01379-0
    By:
    • Shah, Bijal D.;
    • Ghobadi, Armin;
    • Oluwole, Olalekan O.;
    • Logan, Aaron C.;
    • Boissel, Nicolas;
    • Cassaday, Ryan D.;
    • Leguay, Thibaut;
    • Bishop, Michael R.;
    • Topp, Max S.;
    • Tzachanis, Dimitrios;
    • O'Dwyer, Kristen M.;
    • Arellano, Martha L.;
    • Lin, Yi;
    • Baer, Maria R.;
    • Schiller, Gary J.;
    • Park, Jae H.;
    • Subklewe, Marion;
    • Abedi, Mehrdad;
    • Minnema, Monique C.;
    • Wierda, William G.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    PREGNANCY AND ACUTE NEPHRITIS.

    Published in:
    BJOG: An International Journal of Obstetrics & Gynaecology, 1954, v. 61, n. 4, p. 454, doi. 10.1111/j.1471-0528.1954.tb07509.x
    By:
    • O'Dwyer, E. M.;
    • Montgomery, Diana
    Publication type:
    Article